Lung and chest
The question is not which hospital treats the lung nodule. It is how much lung comes out with it.
Wedge resection, segmentectomy and full lobectomy remove very different amounts of working lung, and which one is right depends on whether a tissue diagnosis was made before the operation was proposed.
A lung nodule shows up on a CT scan, and the first honest question is not what operation removes it. It is whether anyone has established what the nodule is before an operation is put on the table at all. A nodule can be sampled with a needle biopsy, sampled through a bronchoscope, or in some cases watched on repeat imaging if it is small and low risk. Moving straight from a scan finding to a scheduled lobectomy answers a question that has not been asked yet.
The second question, once there is a diagnosis, is whether the amount of lung proposed for removal matches what is known about the nodule. A wedge resection takes a narrow margin of tissue around the nodule. A segmentectomy takes a larger, anatomically defined segment. A full lobectomy takes an entire lobe, a substantial working section of the lung. Surgeons sometimes default to the largest of these because it feels safer, not because this particular nodule needs it. The honest question a second opinion should answer is whether the extent of the operation was chosen to match the disease, or chosen to avoid coming back for a second one.
Medically reviewed
Reviewed by Dr Gunjan Patel, MBBS, registered with the Gujarat Medical Council (G-65059). Last reviewed 18 September 2026. Reviewed for accuracy only. This page is general information, not advice about your own case, and Dr Gunjan Patel does not diagnose, prescribe or treat.
Where an opinion helps most
Four situations where a second read changes the plan.
These are the cases where we most often find that the first recommendation was one of several reasonable options rather than the only one.
A nodule found before any biopsy
A scan finding is not a diagnosis. Plenty of lung nodules are infection scars, old granulomas, or benign growths that never needed a knife at all, and plenty are early cancers that do. Until a needle biopsy, a bronchoscopic sample, or a period of watchful imaging has answered which one this is, any conversation about what operation to perform is premature.
When a resection, especially a lobectomy, is proposed before that step, the honest question is why the diagnosis and the operation are being collapsed into one visit.
Early-stage cancer with reduced lung reserve
For a small, peripheral, early-stage tumour, a segmentectomy or even a wedge resection can sometimes remove the disease with a clear margin while leaving more working lung behind than a lobectomy would. That difference matters most for patients who already have reduced lung function from age, smoking history, or another lung condition, where losing an entire lobe changes what daily breathing looks like afterward.
A second opinion here is a question about whether the smaller operation was ever considered, or whether the larger one was chosen by default because it is the more familiar procedure to perform.
Recurrent pneumothorax
A collapsed lung that keeps recurring raises its own extent-of-treatment question, separate from cancer entirely. The choices range from a chest tube and observation, to chemical pleurodesis, to a VATS procedure that staples off the blebs causing the leak and abrades the lining to prevent recurrence.
Which of these is proposed, and how much of the lung surface is treated, should track how many episodes a patient has had and what the imaging shows, not a single default protocol applied to every recurrent case.
Open surgery proposed for a straightforward case
Most wedge resections, segmentectomies, and even many lobectomies can be done through a VATS or robotic-assisted minimally invasive approach rather than an open thoracotomy, with less chest wall trauma and a different recovery. An open approach is still the right call for some anatomy and some larger or centrally located tumours.
When it is proposed for a case that sounds straightforward, the reasonable question is what about this specific case rules the minimally invasive route out, rather than accepting that it simply is not offered.
BEFORE THE LOBE COMES OUT
What to ask before agreeing to a lobectomy
A full lobectomy cannot be undone, and the lung tissue it removes does not grow back, so the questions worth asking are about whether this particular case needed the largest version of the operation.
Ask before the operation is booked
- Has a tissue diagnosis been made, and by what method, before this operation was scheduled?
- Was a wedge resection or segmentectomy considered for this nodule, and if it was ruled out, why?
- What is my current lung function, and what is it expected to be after this specific resection rather than after resection in general?
- Is this planned as VATS or robotic-assisted, and if an open approach is proposed instead, what about my case requires it?
- If the intraoperative frozen section changes the diagnosis, what is the plan, and has that been discussed before I am on the table?
A lobectomy has long been treated as the safe default for a lung tumour, on the reasoning that taking the whole lobe reduces the chance of missing disease at the margin. That reasoning holds for larger or more central tumours. For small, peripheral, early-stage nodules, evidence has increasingly supported sublobar resection, wedge or segmentectomy, as an option that can achieve a comparable outcome while preserving more breathing capacity in patients where that capacity matters.
That isn’t a loose impression. Two randomised trials have tested sublobar resection against full lobectomy directly. 94.3 percent five-year overall survival after segmentectomy for tumours 2 cm or smaller, predominantly solid and node-negative, against 91.1 percent after lobectomy, a statistically significant survival advantage for the smaller operation rather than mere non-inferiority, in a 1,106-patient Japanese randomised trial (JCOG0802/WJOG4607L). 63.6 percent five-year disease-free survival after sublobar resection, wedge or segmentectomy, for peripheral tumours 2 cm or smaller confirmed node-negative during surgery, statistically non-inferior to 64.1 percent after full lobectomy, with predicted lung function (FEV1) at six months roughly 2 percentage points higher after the smaller operation, in a 697-patient US randomised trial run by the Alliance for Clinical Trials in Oncology (CALGB 140503).
Saji H, et al., "Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial", The Lancet, 2022;399(10335):1607-1617 Checked 2026-09-18.
Read from the published abstract directly on pubmed.ncbi.nlm.nih.gov, not the paywalled full text, so Methods and Results detail beyond the abstract was not independently checked. This trial tested segmentectomy specifically, not wedge resection, and enrolled only predominantly solid tumours (consolidation-to-tumour ratio above 0.5) that were node-negative on clinical staging. A related secondary finding: the reduction in FEV1 at one year was about 3.5 percentage points smaller after segmentectomy, a difference the trial’s own authors said was statistically significant but did not reach the gap they had pre-defined as clinically meaningful.
Altorki N, et al., "Lobar or Sublobar Resection for Peripheral Stage IA Non-Small-Cell Lung Cancer", New England Journal of Medicine, 2023;388(6):489-498 Checked 2026-09-18.
Read from the published abstract via Europe PMC’s verbatim reproduction of the NEJM text; nejm.org itself returned a Cloudflare bot-check that was not bypassed, so full-text Results detail beyond the abstract was not independently checked. This trial pools wedge resection and segmentectomy together as "sublobar resection" and required a surgeon to confirm node-negative disease intraoperatively before randomisation, a stricter eligibility gate than clinical staging alone. It is a distinct trial from JCOG0802, which tested segmentectomy on its own in a narrower, predominantly solid tumour population and found a survival advantage rather than equivalence.
The pull toward the bigger operation is not always about the tumour. A lobectomy is a more familiar, more standardised procedure for many surgeons, and it removes the need to be as precise about margins. None of that is a reason to remove more lung than a specific nodule requires, but it is a reason the size of the operation should be checked against the pathology rather than assumed.
The same logic applies to how the operation is done. A minimally invasive approach is now standard for most thoracic resections, and an open thoracotomy proposed without a clear anatomical reason is worth questioning before it is accepted.
An independent second opinion does not repeat the scan. It takes the imaging, the biopsy result if one exists, and the proposed operation, and puts in writing whether the extent and the approach match what is known about the nodule, before the operation is booked rather than after. That review is described in full on /independent-second-opinion.
BEFORE YOU FLY HOME
What thoracic surgery follow-up requires
Chest surgery leaves the lung, and sometimes the chest cavity around it, in a state that needs to be checked before flying is safe, not just before a wound looks healed.
Arrange before you travel home
- Confirmation of when the chest drain came out and a follow-up chest X-ray showing the lung fully re-expanded, not just a verbal clearance to travel.
- The written pathology report, including margins if a resection was done, not a summary given at bedside.
- A clear answer on whether any air or fluid remains in the chest cavity, since trapped air expands at altitude and flying too soon can be dangerous.
- A pain control plan that does not depend on being able to return to the operating hospital for adjustment.
- A named contact and a plan for what to do if fever, worsening breathlessness, or a wound problem appears after leaving India.
Flying after chest surgery is not simply a matter of feeling well enough. Any residual air trapped in the pleural space around the lung will expand at cabin altitude, which is why most surgeons want to see a clear, drain-free chest X-ray before they will clear a patient to fly, and why that confirmation should happen before a return date is booked, not assumed around it.
Recovery of breathing capacity after a resection also takes longer than the incision takes to heal, and a home country pulmonologist will want the operative note, the pathology report, and the discharge imaging in hand at the first follow-up, not requested after the fact from overseas.
The aftercare page at /aftercare covers what to arrange before any procedure abroad, including how records are transferred and how a local doctor is briefed in advance.
Questions
What people ask about lung and chest surgery abroad.
Do I need a biopsy before I travel, or can it be done in India?
It can be done in either place. What matters is that a tissue diagnosis exists, or is scheduled as a distinct step, before an operation is booked. If a hospital is proposing to biopsy and resect in the same visit without a plan for what happens if the frozen section result changes things, that sequencing is worth questioning before you travel, not after.
What is the real difference between VATS and open thoracotomy?
VATS uses small incisions and a camera, with less chest wall trauma and typically a shorter, less painful recovery than an open thoracotomy, which involves spreading the ribs. Most wedge resections, segmentectomies, and many lobectomies can now be done VATS or robotically. An open approach is still sometimes the right choice for larger, central, or anatomically difficult cases, but it should be explained as a decision, not presented as the only option.
If a lobectomy is proposed, can I ask for a smaller resection instead?
You can ask, and a reasonable surgeon will explain why the extent was chosen rather than treat the question as a challenge. Whether a smaller resection is appropriate depends on the size, location, and confirmed nature of the nodule, and on your own lung function. It is not always the right answer, but it should always be an answer that was weighed, not skipped.
Does this page cover lung cancer treatment once a diagnosis is confirmed?
No. This page covers the surgical decision, whether and how much lung tissue is removed. Once a lung cancer diagnosis is confirmed, decisions about staging, chemotherapy, radiation, or a combined treatment plan belong to oncology, not thoracic surgery alone, and that side of the decision is covered on /treatments/oncology.
What about heart or blood vessel surgery inside the chest?
That is a different specialty with a different set of questions and is not covered here. Cardiac and vascular chest surgery, including bypass and valve procedures, is covered on /treatments/cardiac.
Get a second read before a lung operation is booked.
Thirty minutes, free. If the plan you have been given is already the right one, that is what you will hear.